About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Discovery may Cut Down Treatment Doses And Side Effects for Leishmaniasis

by Dr. Enozia Vakil on November 6, 2013 at 8:32 PM
Font : A-A+

 New Discovery may Cut Down Treatment Doses And Side Effects for Leishmaniasis

Amphotericin B (AmB) makes for an important ingredient in the drug used for the treatment of leishmaniasis, a disease that affects more than 12 million people . The cost of treating humans with AmB surpasses $5,000 per patient, the treatment is extensive (2-hour sessions every day during 21 days), and the side effects are frequent and many times patients must be hospitalised.

Researchers from the University of Miami, Florida and the Universitat AutÚnoma de Barcelona have developed a method which allows to drastically reduce the drug dose, since it improves its efficacy 83%, multiplies by 10 the capacity of the drug to attack cell infected by the parasite which provokes the disease, and significantly reduces the toxicity of the parasite. The method has been successfully tested on mice models of leishmaniasis.

Advertisement

The complex compound acts through the action of the PDD nanoparticle, a substance measuring some 10 nanometres in diameter which is fit into the active principle, Amphotericin B, and guides it selectively to the cells harbouring the parasite. Scientists observed how, while the usual complete dose of the drug requires over 12 days to reduce the skin lesions caused by the disease, one dose of the complex compound with only 17% of the complete dose of the drug improves skin lesions in two or three days. Moreover, the complex compound acts as a therapeutic vaccine which activates the immune system against the reservoir cells hosting the parasite.

The PDD substance has been used in previous trials with people with the aim of improving the response of their immune system to other diseases. Now there is a need for clinical trials with humans in order to verify its safety as an adjuvant in the treatment of leishmaniasis. If its safety in humans is confirmed, it will also reduce the cost of the treatment drastically, and this is a key element in reducing mortality rates in developing countries.



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Lifestyle and Wellness News

Shielding Your Skin: Embracing the Power of Sunscreen for Sunlit Days
Significance of sunscreen as an essential element of skincare has experienced a significant upswing in popularity due to the deleterious effects of UV rays.
The Silent Contributor of Workplace Burnout: Influence of Personal Relationships
Impact of workplace burnout on employee performance, wellbeing, and organizational productivity is extensive, yet the role of personal relationships has been overlooked.
 Natural Herbs That Will Give You Youthful, Glowing Skin
Ayurveda offers a time-tested treatment for aging skin using natural herbs and antiquated traditions that value sustainability and might do wonders for skin health.
 Brain Protein Behind High-Salt-Induced Hypertension and Cognitive Impairment
Researchers identified two key physiological systems involved in hypertension, cognitive, and emotional impairments following high salt intake.
Defying Time: Unlocking the Secrets to Wrinkle-Free Skin
Decoding the secrets of wrinkles by knowing the causes, prevention, and expert advice.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Discovery may Cut Down Treatment Doses And Side Effects for Leishmaniasis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests